Clinical Trials

The following information is based on United States guidelines. Please check with your country’s requirements and regulations. To find Clinical Trials from The European Medical Agency go to

If you have questions regarding clinical trials, please contact us.

In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants’ behavior, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. For example, investigators may give a drug or treatment to participants who have high blood pressure to see whether their blood pressure decreases.

Looking for information about clinical trials to give to your patients? Check out our Clinical Trial Information patient page.

Current Clinical Trials

The following clinical trials are automatically generated from


  • Conditions:   Age-Related Macular Degeneration;   Allergies;   Alpha-Gal Syndrome;   Alzheimer Disease;   Amyloidosis;   Ankylosing Spondylitis;   Arthritis;   Alopecia Areata;   Asthma;   Atopic Dermatitis;   Autism;   Autoimmune Hepatitis;   Behcet's Disease;   Beta-Thalassemia;   Cancer;   Celiac Disease;   Kidney Diseases;   COPD;   Crohn Disease;   Cystic Fibrosis;   Diabetes;   Dravet Syndrome;   DMD;   Fibromyalgia;   Graves Disease;   Thyroid Diseases;   Hepatitis;   Hidradenitis Suppurativa;   ITP;   Leukemia;   ALS;   Lupus or SLE;   Lymphoma;   Multiple Sclerosis;   Myasthenia Gravis;   Heart Diseases;   Parkinson Disease;   Pemphigus Vulgaris;   Cirrhosis;   Psoriasis;   Schizophrenia;   Scleroderma;   Sickle Cell Disease;   Stroke;   Ulcerative Colitis;   Vasculitis;   VitiligoIntervention:   Diagnostic Test: Specimen sampleSponsor:   Sanguine BiosciencesRecruiting
  • Conditions:   Pemphigus Vulgaris;   Bullous PemphigoidInterventions:   Drug: Ozonated olive oil;   Drug: Topical garamycin creamSponsor:   Cairo UniversityRecruiting
  • Condition:   PemphigusIntervention:   Other: Investigator Global Assessments (IGAs)Sponsor:   Premier Specialists, AustraliaRecruiting
  • Condition:   Pemphigus VulgarisInterventions:   Drug: Abatacept Prefilled Syringe;   Drug: Mycophenolate Mofetil 500Mg TabSponsors:   Tongji Hospital;   Wuhan Central Hospital;   Wuhan Hospital of Traditional Chinese MedicineRecruiting
  • Conditions:   Pemphigus;   Bullous Pemphigoid;   Stevens-Johnson Syndrome;   Toxic Epidermal NecrolysesIntervention:   Genetic: A single blood sample for HLA typingSponsors:   Sechenov University;   Pirogov Russian National Research Medical UniversityRecruiting
  • Conditions:   Rheumatoid Arthritis (RA);   Systemic Lupus Erythematosus (SLE);   Pemphigus Vulgaris;   Multiple Sclerosis (MS);   Systemic Sclerosis (SSc);   Pediatric SLE;   Juvenile Idiopathic Arthritis (JIA);   Juvenile Dermatomyositis (JDM);   Pediatric-Onset Multiple Sclerosis (POMS)Interventions:   Biological: Moderna mRNA-1273;   Biological: BNT162b2;   Biological: Ad26.COV2.S;   Drug: Continue IS (MMF or MPA);   Drug: Continue IS (MTX);   Biological: Continue IS (B cell depletion therapy);   Biological: Monovalent [B.1.351] CoV2 preS dTM-AS03;   Drug: Withhold IS (MMF or MPA);   Drug: Withhold IS (MTX);   Drug: Withhold IS (B cell depletion therapy);   Biological: Moderna mRNA-1273, Bivalent;   Biological: BNT162b2, BivalentSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Autoimmunity Centers of Excellence;   Rho Federal Systems Division, Inc.Recruiting
  • Conditions:   Relapsing Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Primary Progressive Multiple SclerosisInterventions:   Drug: Rituximab;   Drug: Ocrelizumab;   Drug: Fexofenadine;   Drug: Paracetamol;   Drug: MethylprednisoloneSponsors:   Rigshospitalet, Denmark;   Odense University Hospital;   Aarhus University Hospital;   Aalborg University Hospital;   Herlev Hospital;   Hillerod Hospital, Denmark;   Zealand University Hospital;   Kolding Sygehus;   Regional Hospital Holstebro;   Hvidovre University Hospital;   Hospital of South West Jutland, Esbjerg, Denmark;   GCP unit, Copenhagen University Hospital;   GCP-unit at Aarhus University Hospital, Aarhus, Denmark;   Hospital of Southern Jutland, Sønderborg, Denmark;   Hospital of Central Denmark Region, Viborg, Denmark;   Danske RegionerRecruiting
  • Conditions:   Pemphigus Vulgaris;   Pemphigus FoliaceusInterventions:   Biological: efgartigimod PH20 SC;   Drug: prednisoneSponsor:   argenxRecruiting
  • Condition:   Autoimmune Bullous DiseaseIntervention:   Procedure: BiopsySponsor:   Gangnam Severance HospitalRecruiting
  • Condition:   Mucosal -Dominant Pemphigus VulgarisIntervention:   Biological: DSG3-CAARTSponsor:   Cabaletta BioRecruiting